非小细胞肺癌的射频消融治疗

结核病与肺部健康杂志 ›› 2013, Vol. 2 ›› Issue (1): 19-21.

非小细胞肺癌的射频消融治疗

黄乃祥，陈溯，盛冬生

100071 北京, 军事医学科学院附属医院胸外科

收稿日期:2013-04-05 出版日期:2013-03-30 发布日期:2013-03-30
通信作者: 黄乃祥, Email: huangnx6219@sina.com

Clinical application of radiofrequency ablation for non-small cell lung cancer

HUANG Nai-xiang,CHEN Su,SHENG Dong-sheng

the Thoracic Surgery Department of Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China

Received:2013-04-05 Online:2013-03-30 Published:2013-03-30
Contact: HUANG Nai-xiang,Email: huangnx6219@sina.com

摘要/Abstract

摘要： 目的探讨射频消融治疗非小细胞肺癌的疗效及应用价值。方法搜集我院2004年4月至2012年12月收治的1373例非小细胞肺癌患者, 可进行疗效评价的患者1236例,共1384个病灶均采用射频消融治疗。观察其近期疗效、中位生存期及1～5年的生存率。结果本组患者治疗的有效率是92.15%(1139/1236)。1年生存者672例,1年生存率为54.37%(672/1236);2年生存者201例,2年生存率40.52%(201/496);3年生存者87例,3年生存率15.10%(87/576);5年生存者22例,5年生存率9.61%(22/229)。结论射频消融治疗非小细胞肺癌的早期、中期效果满意。

Abstract: Objective To evaluate the therapeutic effect and application value of radiofrequency ablation (RAF) for advanced non-small cell lung cancer (NSCLC).Methods From April 2004 to December 2012 1373 patients with NSCLC were treated by RAF. The early treatment results, median survival time and 1-5 year survival rates were observed.Results The effective rate (CR+PR+NC/CR+PR+NC+PD)was 92.15%(1139/1236). 672 cases survived over one year and the 1 year survival rate was 54.37% (672/1236). Two hundred and one cases survived over 2 years and the 2 year survival rate was 40.52% (201/496). Eighty-seven cases survived over three years and the 3 year survival rate was 15.10%(87/576). Twenty-two cases survived over 5 years and the 5 year survival rate was 9.61% (22/229).Conclusion The early and mid-term effects of RAF on non-small cell lung cancer is satisfactory.

黄乃祥，陈溯，盛冬生. 非小细胞肺癌的射频消融治疗[J]. 结核病与肺部健康杂志, 2013, 2(1): 19-21.

HUANG Nai-xiang,CHEN Su,SHENG Dong-sheng. Clinical application of radiofrequency ablation for non-small cell lung cancer[J]. Journal of Tuberculosis and Lung Health, 2013, 2(1): 19-21.